At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Indoles; Small molecules; Sulfonamides
- Mechanism of Action Serotonin 4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes